Anzeige
Mehr »
Montag, 20.04.2026 - Börsentäglich über 12.000 News
China - das Pentagon - und dieses Unternehmen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

JAPAN 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im JAPAN

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
14:00Astellas, Pfizer Say FDA Grants Priority Review To SBLA For PADCEV Plus Keytruda85TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY) and Pfizer Inc. (PFE) on Monday said the U.S. Food and Drug Administration has granted Priority Review for a supplemental Biologics License Application...
► Artikel lesen
13:59Hitachi Energy to supply automation solutions for RWE wind project5
13:49Honda zieht bei reinen E-Autos den Stecker2
13:42Asahi Kasei completes acquisition of German biotech Aicuris3
13:39Japan Airlines setzt auf Recaro-Sitze für neue Boeing 737 Max7
13:36Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy128 Aicuris's three antiviral assets complement Asahi Kasei's therapy portfolio Aicuris revenue expected to reach $500 million by 2030 FDA has granted Priority Review for the pritelivir...
► Artikel lesen
13:30Pfizer, Astellas win FDA priority review for Padcev in bladder cancer with Merck's Keytruda9
13:15PlayStation-Legende Shuhei Yoshida sagt, Jim Ryan habe ihn gefeuert, weil er nicht auf ihn hörte4
13:10Erfolgsmeldung von Capcom: Pragmata feiert nach nur zwei Tagen den ersten Meilenstein1
12:54JAL, ANA to Double Fuel Surcharges in May3
12:45Astellas Pharma Inc.: U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility72Submission based on statistically significant event-free and overall survival data from the Phase 3 EV-304 trial Building on the existing indication in cisplatin-ineligible...
► Artikel lesen
12:41OKEA Sells 20% Stake in Norwegian Sea License to Japex for $30M2
12:36Ushio Industry & Entertainment Appoints Takuya Matsumoto as President & CEO and Outlines Strategic Direction for the Next Phase174 Ushio Industry Entertainment (Ushio INE GmbH) announces the appointment of Takuya Matsumoto as President and Chief Executive Officer, marking a key milestone in the evolution of the business and...
► Artikel lesen
11:58Fujitsu Ltd: Fujitsu launches GLOVIA One ERP solution for mid-sized Japanese enterprises147Standard AI agent visualizes data and supports decision-making to advance management and operationsKAWASAKI, Japan, Apr 20, 2026 - (JCN Newswire) - Fujitsu Limited today announced the integration of...
► Artikel lesen
11:54Kirin Unit to Offer Further Support for Wineries in Japan6
11:42Hitachi, FQM advance battery-electric haulage at Kansanshi mine4
11:30Mitsui's Zipangcoin brings precious metals to blockchain3
11:18NTT DATA Becomes First Network Operator in Africa to Launch 400 Gbps Peering at JINX2
11:15MUFG selects Finastra Global PAYplus for US ACH payments2
11:10EcoGraf Limited: Absichtserklärung mit Mitsubishi Chemical über 10.000 Tonnen Graphit14
Weiter >>